R.M. Davis Inc’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,673
| Closed | -$217K | – | 275 |
|
|
2024
Q2 | $217K | Buy |
3,673
+663
| +22% | +$41.5K | ﹤0.01% | 263 |
|
|
2024
Q1 | $240K | Buy |
3,010
+242
| +9% | +$18.5K | 0.01% | 243 |
|
|
2023
Q4 | $219K | Sell |
2,768
-531
| -16% | -$37.8K | 0.01% | 254 |
|
|
2023
Q3 | $230K | Sell |
3,299
-1,216
| -27% | -$86.2K | 0.01% | 251 |
|
|
2023
Q2 | $312K | Sell |
4,515
-965
| -18% | -$68.7K | 0.01% | 232 |
|
|
2023
Q1 | $407K | Sell |
5,480
-663
| -11% | -$55.6K | 0.01% | 195 |
|
|
2022
Q4 | $572K | Buy |
6,143
+675
| +12% | +$65.1K | 0.02% | 173 |
|
|
2022
Q3 | $521K | Sell |
5,468
-182
| -3% | -$18K | 0.02% | 169 |
|
|
2022
Q2 | $524K | Sell |
5,650
-223
| -4% | -$21.8K | 0.01% | 174 |
|
|
2022
Q1 | $594K | Buy |
5,873
+1,830
| +45% | +$192K | 0.01% | 172 |
|
|
2021
Q4 | $417K | Buy |
4,043
+490
| +14% | +$45.3K | 0.01% | 199 |
|
|
2021
Q3 | $302K | Sell |
3,553
-116
| -3% | -$9.72K | 0.01% | 223 |
|
|
2021
Q2 | $306K | Hold |
3,669
| – | – | 0.01% | 221 |
|
|
2021
Q1 | $276K | Sell |
3,669
-215
| -6% | -$15.7K | 0.01% | 227 |
|
|
2020
Q4 | $265K | Buy |
+3,884
| New | +$253K | 0.01% | 237 |
|
|
2020
Q3 | – | Sell |
-3,491
| Closed | -$227K | – | 246 |
|
|
2020
Q2 | $227K | Sell |
3,491
-1,713
| -33% | -$108K | 0.01% | 217 |
|
|
2020
Q1 | $309K | Buy |
5,204
+2,211
| +74% | +$148K | 0.01% | 176 |
|
|
2019
Q4 | $222K | Buy |
+2,993
| New | +$210K | 0.01% | 232 |
|
|
2019
Q1 | – | Sell |
-3,601
| Closed | -$236K | – | 226 |
|
|
2018
Q4 | $236K | Sell |
3,601
-3,457
| -49% | -$258K | 0.01% | 199 |
|
|
2018
Q3 | $556K | Buy |
7,058
+504
| +8% | +$36K | 0.02% | 156 |
|
|
2018
Q2 | $422K | Sell |
6,554
-2,550
| -28% | -$168K | 0.02% | 169 |
|
|
2018
Q1 | $566K | Buy |
9,104
+37
| +0.4% | +$2.65K | 0.02% | 155 |
|
|
2017
Q4 | $657K | Sell |
9,067
-203
| -2% | -$14.8K | 0.03% | 151 |
|
|
2017
Q3 | $754K | Buy |
9,270
+2,683
| +41% | +$212K | 0.03% | 138 |
|
|
2017
Q2 | $530K | Sell |
6,587
-3,845
| -37% | -$304K | 0.02% | 151 |
|
|
2017
Q1 | $819K | Sell |
10,432
-27
| -0.3% | -$2.16K | 0.04% | 131 |
|
|
2016
Q4 | $825K | Sell |
10,459
-731
| -7% | -$59.1K | 0.04% | 131 |
|
|
2016
Q3 | $996K | Buy |
11,190
+800
| +8% | +$75.5K | 0.05% | 123 |
|
|
2016
Q2 | $995K | Buy |
10,390
+2,273
| +28% | +$227K | 0.05% | 123 |
|
|
2016
Q1 | $842K | Sell |
8,117
-320
| -4% | -$31.1K | 0.04% | 127 |
|
|
2015
Q4 | $825K | Buy |
8,437
+136
| +2% | +$13.3K | 0.04% | 124 |
|
|
2015
Q3 | $801K | Sell |
8,301
-843
| -9% | -$88.6K | 0.04% | 129 |
|
|
2015
Q2 | $959K | Buy |
9,144
+483
| +6% | +$49.3K | 0.05% | 118 |
|
|
2015
Q1 | $894K | Sell |
8,661
-216
| -2% | -$21.9K | 0.05% | 120 |
|
|
2014
Q4 | $855K | Buy |
8,877
+225
| +3% | +$19.8K | 0.05% | 123 |
|
|
2014
Q3 | $689K | Buy |
8,652
+1,617
| +23% | +$127K | 0.04% | 128 |
|
|
2014
Q2 | $530K | Buy |
7,035
+832
| +13% | +$62.9K | 0.03% | 137 |
|
|
2014
Q1 | $464K | Sell |
6,203
-1,760
| -22% | -$124K | 0.03% | 137 |
|
|
2013
Q4 | $570K | Sell |
7,963
-4,305
| -35% | -$277K | 0.03% | 128 |
|
|
2013
Q3 | $696K | Sell |
12,268
-1,100
| -8% | -$65.5K | 0.05% | 120 |
|
|
2013
Q2 | $764K | Buy |
+13,368
| New | +$774K | 0.05% | 116 |
|
Other funds holding CVS
R.M. Davis Inc's CVS Position: Q3 2024 in Review
R.M. Davis Inc sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,673 shares — an estimated $217K sold.
R.M. Davis Inc first reported a position in CVS in Q2 2013 and held it in 41 quarters. The position peaked at $996K in Q3 2016. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- R.M. Davis Inc reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- R.M. Davis Inc sold 3,673 CVS Health shares in Q3 2024, an estimated $217K.
- R.M. Davis Inc first reported a position in CVS Health in Q2 2013 and held it in 41 quarters.
- R.M. Davis Inc's CVS Health position peaked at $996K in Q3 2016.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on R.M. Davis Inc's 13F filing for Q3 2024, filed 13 Nov 2024.